UROV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
UROV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Receipts from Government Grants only applicable to companies reporting Cash Flow from Operations in direct method.
Myrtle S Potter | director | 10 FINDERNE AVE, BRIDGEWATER NJ 08807 |
Sef Kurstjens | director | C/O UROVANT SCIENCES, INC. 5281 CALIFORNIA AVENUE, SUITE 100 IRVINE CA 92617 |
Pierre Legault | director | P.O. BOX 1028, C/O STONE MANAGEMENT LLC, BERWYNE PA 19312 |
James M. Hindman | director | 2525 DUPONT DRIVE, IRVINE CA 92612 |
Walt Johnston | officer: SVP, Commercial, USI | UROVANT SCIENCES LTD. 5281 CALIFORNIA AVE SUITE 100 IRVINE CA 92617 |
Haag-molkenteller Cornelia | officer: CMO/Urovant Sciences, Inc. | C/O UROVANT SCIENCES, INC. 5281 CALIFORNIA AVENUE, SUITE 100 IRVINE CA 92617 |
Bryan E. Smith | officer: GC/Urovant Sciences, Inc. | C/O UROVANT SCIENCES, INC., 5281 CALIFORNIA AVENUE, SUITE 100, IRVINE CA 92617 |
Christine Ocampo | officer: PAO;CAO/Urovant Sciences, Inc | C/O UROVANT SCIENCES, INC., 5281 CALIFORNIA AVENUE, SUITE 100, IRVINE CA 92617 |
Ajay Bansal | officer: PFO;CFO/Urovant Sciences, Inc. | C/O UROVANT SCIENCES, INC., 5281 CALIFORNIA AVENUE, SUITE 100, IRVINE CA 92617 |
Robinson James A. Jr. | director, officer: PEO;CEO/Urovant Sciences, Inc. | 852 WINTER STREET, WALTHAM MA 02451 |
Sumitomo Chemical Co., Ltd. | other: See Footnote (1) | 7-1, NIHONBASHI 2-CHOME, CHUO-KU, TOKYO M0 103-6020 |
Sumitovant Biopharma Ltd. | 10 percent owner | C/O ROIVANT SCIENCES, INC., 320 WEST 37TH STREET, 5TH FLOOR, NEW YORK NY 10018 |
Dainippon Sumitomo Pharma Co Ltd | other: See Footnote (1) | 6-8 DOSHOMACHI 2-CHOME, CHUO-KU, OSAKA M0 541-0045 |
Keith Katkin | director, officer: PEO;CEO/Urovant Sciences, Inc. | C/O UROVANT SCIENCES, INC., 5281 CALIFORNIA AVENUE, SUITE 100, IRVINE CA 92617 |
Shigeyuki Nishinaka | director | 5281 CALIFORNIA AVENUE, SUITE 100, IRVINE CA 92617 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.